Source comparison
The Honest Truth About CJC-1295 No DAC vs DAC Variants
Here's the blunt answer: the 'No DAC' designation isn't a minor formulation difference. It fundamentally changes how you cycle the peptide. CJC-1295 with DAC (Drug Affinity Complex) extends the half-life to approximately 8 days through albumin binding, creatin
This comparison does not assign a generated winner or score.
- Here's the blunt answer: the 'No DAC' designation isn't a minor formulation difference. It fundamentally changes how you cycle the peptide. CJC-1295 with DAC (Drug Affinity Complex) extends the half-life to approximately 8 days through albumin binding, creating sustained GH elevation that mimics exogenous GH replacement more than natural pulsatile secretion. CJC-1295 No DAC has a half-life of 30 minutes, requiring multiple daily doses but preserving the natural GH pulse amplitude that prevents receptor downregulation.
- The cycling implication: CJC-1295 with DAC typically follows 4-week cycles with equal off-periods because the sustained elevation suppresses natural pulse patterns. CJC-1295 No DAC allows 8–12 week cycles specifically because it works with. Not against. Endogenous pulsatile architecture. Research protocols using CJC-1295 No DAC combined with ipamorelin (a ghrelin mimetic that triggers GH release through a separate receptor pathway) demonstrate synergistic effects that extend viable cycling windows compared to single-peptide protocols.